On April 30, 2013, a Texas resident filed a lawsuit over the wrongful death of a woman who was taking Dabigatran. The lawsuit was filed in U.S. District Court by the family of a woman who died after taking Dabigatran as a treatment for atrial fibrillation (AF).
In the complaint, the woman is said to have died from gastrointestinal bleeding that was caused by her use of Dabigatran. The lawsuit has been transferred to the coordinated proceedings taking place in the U.S. District Court, Southern District of Illinois. The plaintiffs in the case state that the deceased, Wilma Parnell, was unaware of the bleeding risks involved in taking Dabigatran when she first started taking the drug. She died shortly after beginning the drug, after suffering from uncontrollable bleeding, which is a side effect that has been linked to Dabigatran use.
While Dabigatran was initially expected to be a safer alternative to the AF drug Warfarin, it has since proven to be very dangerous. And although patients taking Warfarin are usually given vitamin K to stop the bleeding when taking the drug, it has been discovered that there is no way to stop the bleeding while taking Dabigatran. Anticoagulants are generally used to treat patients with AF. Still, both drugs are considered safer to use than the controversial Multaq. Multaq is made by Sanofi-Aventis and has been linked to serious side effects including a worsening of the heart condition, liver failure and lung toxicity. It is for this reason that the FDA has recommended that doctors only prescribe Multaq if all other medications fail to work.
If you or a loved one has suffered from liver failure or a worsening heart condition after being treated with Multaq, contact the attorneys at Greg Jones today for a free consultation. I am experienced at fighting Multaq lawsuits and may be able to help you recover money for your injuries.